- Home
- LMT vs BMY Comparison
LMT vs BMY Comparison
Compare LMT & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMT
- BMY
- Stock Information
- Founded
- LMT 1912
- BMY 1887
- Country
- LMT United States
- BMY United States
- Employees
- LMT 121000
- BMY N/A
- Industry
- LMT Military/Government/Technical
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- LMT Industrials
- BMY Health Care
- Exchange
- LMT Nasdaq
- BMY Nasdaq
- Market Cap
- LMT 106.1B
- BMY 94.0B
- IPO Year
- LMT N/A
- BMY N/A
- Fundamental
- Price
- LMT $458.15
- BMY $46.60
- Analyst Decision
- LMT Buy
- BMY Hold
- Analyst Count
- LMT 14
- BMY 14
- Target Price
- LMT $518.79
- BMY $57.54
- AVG Volume (30 Days)
- LMT 1.4M
- BMY 16.3M
- Earning Date
- LMT 10-21-2025
- BMY 10-30-2025
- Dividend Yield
- LMT 3.01%
- BMY 5.31%
- EPS Growth
- LMT N/A
- BMY N/A
- EPS
- LMT 17.88
- BMY 2.97
- Revenue
- LMT $73,349,000,000.00
- BMY $48,034,000,000.00
- Revenue This Year
- LMT $5.97
- BMY N/A
- Revenue Next Year
- LMT $4.24
- BMY N/A
- P/E Ratio
- LMT $25.63
- BMY $15.72
- Revenue Growth
- LMT 2.88
- BMY 1.26
- 52 Week Low
- LMT $410.11
- BMY $42.52
- 52 Week High
- LMT $576.43
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- LMT 29.00
- BMY 62.27
- Support Level
- LMT $479.87
- BMY $45.38
- Resistance Level
- LMT $494.46
- BMY $46.66
- Average True Range (ATR)
- LMT 9.43
- BMY 1.01
- MACD
- LMT -3.83
- BMY 0.40
- Stochastic Oscillator
- LMT 9.43
- BMY 94.07
About LMT Lockheed Martin Corporation
Lockheed Martin is the world's largest defense contractor and has dominated the Western market for high-end fighter aircraft since it won the F-35 Joint Strike Fighter program in 2001. Aeronautics is Lockheed's largest segment, which derives upward of two-thirds of its revenue from the F-35. Lockheed's remaining segments are rotary and mission systems, mainly encompassing the Sikorsky helicopter business; missiles and fire control, which creates missiles and missile defense systems; and space systems, which produces satellites and receives equity income from the United Launch Alliance joint venture.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.